Buy Venlafaxine pills online
How and where to order Venlafaxine (Effexor, Effexor XR) 37.5 mg, 75 mg, 150 mg capsules or tablets online:
| Shop: | DFH PHARMACY - 10% discount coupon DFH10
|
| Sellers: | VENLAFAXINE STORES
|
| Prices: | from $0.44 per pill
|
| Forms: | capsules and tablets
|
| Quantity: | 30-360 pills
|
| Type: | Effexor, Effexor XR brands and generics
|
| Payment: | Visa, Mastercard, AmEx, Cryptocurrencies
|
| Delivery: | Regular and express mail service
|
| Shipping: | Worldwide, including USA, UK, Europe, Canada, Australia |
Indications and usage:
Venlafaxine (Effexor, Effexor XR) is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with:
depression
major depressive disorder
postpartum depression
generalized anxiety disorder
social anxiety disorder
panic disorder
diabetic neuropathy
premenstrual dysphoric disorder
bipolar disorder
borderline personality disorder
obsessive compulsive disorder
vasomotor symptoms
post-traumatic stress disorder
attention deficit-hyperactivity disorder
dissociative identity disorder
irritable bowel syndrome
back pain, chronic pain, fibromyalgia, somatoform pain disorder
vulvodynia
bulimia
cataplexy
autism
sleep disorder
narcolepsy
migraine
Contraindications:
Hypersensitivity to venlafaxine hydrochloride, desvenlafaxine succinate, or any excipients in the drug formulation.
Concomitant use of monoaminoxidase inhibitors or within 14 days of discontinuing an MAOI.
Dosage forms and strengths:
Effexor XR (Venlafaxine) extended-release capsules 37.5 mg, 75 mg, 150 mg.
Dosage and administration:
| Maximum Dose |
Starting Dose |
Target Dose |
Maximum Dose |
| Major depressive disorder |
37.5-75 mg/day |
75 mg/day |
225 mg/day |
| Generalized anxiety disorder |
37.5-75 mg/day |
75 mg/day |
225 mg/day |
| Social anxiety disorder |
75 mg/day |
75 mg/day |
75 mg/day |
| Panic disorder |
37.5 mg/day |
75 mg/day |
225 mg/day |
Take once daily with food. Capsules should be taken whole; do not divide, crush, chew, or dissolve.
When discontinuing treatment, reduce the dose gradually.
Renal impairment: reduce the total daily dose by 25% to 50% in patients with renal impairment. Reduce the total daily dose by 50% or more in patients undergoing dialysis or with severe renal impairment.
Hepatic impairment: reduce the daily dose by 50% in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment or hepatic cirrhosis, it may be necessary to reduce the dose
by more than 50%.
Warnings and precautions:
Serotonin syndrome: increased risk when co-administered with other serotonergic agents, but also when taken alone. If it occurs, discontinue venlafaxine and serotonergic agents and initiate supportive treatment.
Elevated blood pressure: control hypertension before initiating treatment. Monitor blood pressure regularly during treatment.
Increased risk of bleeding: concomitant use of aspirin, NSAIDs, other antiplatelet drugs, warfarin, other anticoagulants may increase risk.
Angle-closure glaucoma: angle-closure glaucoma has occurred in patients with untreated anatomically narrow angles, treated with antidepressants.
Activation of mania or hypomania: screen patients for bipolar disorder.
Discontinuation syndrome: taper dose and monitor for discontinuation symptoms.
Seizures: can occur. Use cautiously in patients with seizure disorder.
Hyponatremia: can occur in association with SIADH.
Interstitial lung disease and eosinophilic pneumonia: can occur.
Sexual Dysfunction: Effexor XR may cause symptoms of sexual dysfunction.
Overdosage:
No specific antidotes for venlafaxine capsules and tablets are known. In managing overdosage, consider the possibility of multiple drug involvement. Consider contacting a poison center or a medical toxicologist for overdosage management recommendations.
Side effects, adverse reactions:
Most common adverse reactions of venlafaxine (incidence >= 5% and at least twice the rate of placebo): somnolence, nausea, dry mouth, abnormal ejaculation, sweating, anorexia, men impotence, libido decreased, constipation.
To report suspected side effects of Effexor XR (Venlafaxine) pills contact Pfizer, Viatris pharmaceutical companies, or your local FDA.
Drug interactions:
The concomitant use of SNRIs, including venlafaxine, with Monoamine Oxidase Inhibitors (MAOI) and other serotonergic drugs (including other SNRIs, SSRIs, triptans, tricyclic antidepressants, opioids, lithium, buspirone, amphetamines, tryptophan, and St. John's Wort) increases the risk of serotonin syndrome.
Concomitant use of Effexor with an antiplatelet or anticoagulant drug may potentiate the risk of bleeding.
Concomitant use of a CYP3A inhibitor may increase the risk of toxicity of venlafaxine pills.
The risk of using venlafaxine concomitantly with other central nervous system active drugs drugs (including alcohol) has not been systematically evaluated.
Concomitant use of Venlafaxine (Effexor XR) and weight loss agents is not recommended. The safety and efficacy of therapy in combination with weight loss agents, including phentermine, have not been established.
Usage in specific populations:
Pregnancy
Third trimester use may increase risk for symptoms of poor neonatal adaptation (respiratory distress, temperature instability, feeding difficulty, hypotonia, tremor, irritability) in the neonate.
Lactation
Data from published literature report the presence of venlafaxine and its active metabolite in human milk and have not shown adverse reactions in breastfed infants. There are no data on the effects of venlafaxine on milk production.
Pediatric use
Safety and effectiveness of Effexor XR in pediatric patients have not been established.
Geriatric use
No overall differences in effectiveness or safety were observed between geriatric patients and younger patients, and other reported clinical experience generally has not identified differences in response between the elderly and younger patients.
Hepatic impairment
Dosage adjustment is recommended in patients with mild (Child-Pugh Class A), moderate (Child-Pugh Class B), or severe (Child-Pugh Class C) hepatic impairment or hepatic cirrhosis.
Renal impairment
Dosage adjustment is recommended in patients with mild (CLcr = 60-89 mL/min), moderate (CLcr = 30-59 mL/min), or severe (CLcr < 30 mL/min) renal impairment, and in patients undergoing hemodialysis.
Drug abuse and dependence:
Controlled substance
Venlafaxine is not a controlled substance in most of countries worldwide.
Abuse
While Effexor XR has not been systematically studied in clinical studies for its potential for abuse, there was no indication of drug-seeking behavior in the clinical studies. However, it is not possible to predict on the basis of premarketing experience the extent to which a CNS-active drug will be misused, diverted, and/or abused once marketed. Consequently, providers should carefully evaluate patients for history of drug abuse and follow such patients closely, observing them for signs of misuse or abuse of venlafaxine (e.g., development of tolerance, incrementation of dose, drug-seeking behavior).
Dependence
Effexor XR was not found to have any significant CNS stimulant activity in rodents. In primate drug discrimination studies, venlafaxine showed no significant stimulant or depressant abuse liability.
Where to buy venlafaxine online:
To purchase Effexor, Effexor XR (Venlafaxine) 37.5 mg, 75 mg, 150 mg capsules and tablets from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.
Here is a list of popular medications containing venlafaxine as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
| Trade name of the drug |
Pharmaceutical forms and doses |
Companies |
| Efexor |
Tablets; Oral; 37.5 mg, 50 mg, 75 mg |
PfizerWyeth |
| Effexor |
Capsules, Prolonged Release; Oral; 37.5 mgTablets; Oral; 12.5 mg, 25 mg, 37.5 mg, 50 mg, 75 mg, 100 mg |
PfizerViatrisWyeth |
| Effexor XR |
Capsules, Extended Release; Oral; 37.5 mg, 75 mg, 100 mg, 150 mg |
PfizerViatrisWyeth |
| Venlor |
Tablets; Oral; 25 mg, 37.5 mg, 75 mg |
Cipla |
| Venlor XR |
Capsules, Extended Release; Oral; 37.5 mg, 75 mg, 150 mg |
Cipla |